Vaping Clinical Trial - Network Intervention to Prevent Vaping

Status Enrolling by invitation

Clinical Trial Summary

Rates of adolescent vaping are increasing rapidly. Current high school student use of electronic vaping products (EVPs) rose from 1.5% in 2011 to 20.8% in 2018 - an increase from 220,000 to 3.05 million adolescent users. Effective, school-based interventions are urgently needed to protect adolescents from initiating or continuing use of electronic vaping products (EVPs). This study leverages a state-supported prevention initiative to test the effectiveness of a promising intervention that trains 8th-9th grade student peer leaders to deliver school-wide vaping prevention campaigns with ongoing adult mentoring. If study hypotheses are supported, the study will provide the first evidence of a school-based preventive intervention that reduces adolescent vaping behaviors, as well as insight into how peer communications can be harnessed to prevent vaping.

Clinical Trial Description

Above the Influence of Vaping (ATI-V) trains peer nominated 8th-9th grade Peer Leader, and adult advisors. Peer Leaders learn skills and implement school-wide prevention campaigns informed by communication science.New York State has provided funds to support schools to implement ATI-V but no funds for efficacy research. With support from New York State and a strong team of investigators, our project has two aims: Aim 1. Efficacy. The primary aim of this study is to determine ATI-V impact in preventing vaping use (past 30 days any vaping, nicotine vaping, and regular use). Using an RCT design, 20 schools will be assigned to (a) immediate ATI-V, or (b) wait-list for ATI-V training after 24 months. Approximately 3,800 8th graders will be enrolled and followed for assessments in fall 8th grade, spring 8th grade, spring 9th grade, and mid-year 10th grade. We will test for which students ATI-V is most effective and in what school contexts (school climate). Aim 2. Mechanism. The second aim of this study to test the hypothesized mechanisms of ATI-V impact. To accomplish this aim we will conduct statistical analyses of a mediation model to determine (a) whether ATI-V improves students' perceptions that vaping is unacceptable to their peers (anti-vaping norms), connections to supportive adults to address EVP concerns, and social influence of non-vaping students; and (b) whether the impact of ATI-V on reduced vaping behavior is mediated by these improvements. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04678245
Study type	Interventional
Source	University of Rochester
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	September 1, 2020
Completion date	February 28, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05037656` - Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths	N/A
Recruiting	`NCT05454267` - Early Detection of Vaping-related Vascular Diseases
Recruiting	`NCT06297005` - The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study
Not yet recruiting	`NCT05999383` - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration	Phase 2
Completed	`NCT04522362` - Modeling Stress-precipitated Vaping Behavior	N/A
Completed	`NCT04054765` - A Virtual Reality Videogame for E-cigarette Prevention in Teens	N/A
Recruiting	`NCT06291597` - Vaping Adverse Lung and Heart Events Cohort
Active, not recruiting	`NCT04919590` - Text Message Quit Vaping Intervention for Adolescents	N/A
Completed	`NCT04568395` - Acute Effects of TCIG vs ECIG in PLWH	N/A
Active, not recruiting	`NCT04707911` - Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents	N/A
Withdrawn	`NCT04340700` - Characterization of the Pharmacodynamic Response to Vaped THC	Phase 3
Not yet recruiting	`NCT06335329` - Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping	N/A
Not yet recruiting	`NCT06274723` - Responses to E-cigarette Message Source and Presentation	N/A
Active, not recruiting	`NCT05488743` - Smoking Prevention Program in Poland
Terminated	`NCT05240027` - To Vape or Not to Vape	N/A
Recruiting	`NCT04661683` - Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol	N/A
Completed	`NCT04450537` - PACE Vape Messaging Study	N/A
Active, not recruiting	`NCT05367492` - Varenicline for Nicotine Vaping Cessation in Adolescents	Phase 4
Completed	`NCT04879225` - Menthol and Mint Experimental Tobacco Marketplace (ETM) Study	N/A
Completed	`NCT04836455` - Impact of Vaping Prevention Advertisements	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.